Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma

Background The heterogeneity of lung adenocarcinoma (LUAD) plays a vital role in determining the development of cancer and therapeutic sensitivity and significantly hinders the clinical treatment of LUAD.Objective To elucidate the cellular composition and reveal previously uncharacterised tumour mic...

Full description

Bibliographic Details
Main Authors: Lei Cheng, Tianqing Chu, Haijiao Lu, Jialin Qian, Yinchen Shen, Chaoxian Zhao
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:BMJ Open Respiratory Research
Online Access:https://bmjopenrespres.bmj.com/content/10/1/e001878.full
_version_ 1797369288745549824
author Lei Cheng
Tianqing Chu
Haijiao Lu
Jialin Qian
Yinchen Shen
Chaoxian Zhao
author_facet Lei Cheng
Tianqing Chu
Haijiao Lu
Jialin Qian
Yinchen Shen
Chaoxian Zhao
author_sort Lei Cheng
collection DOAJ
description Background The heterogeneity of lung adenocarcinoma (LUAD) plays a vital role in determining the development of cancer and therapeutic sensitivity and significantly hinders the clinical treatment of LUAD.Objective To elucidate the cellular composition and reveal previously uncharacterised tumour microenvironment in LUAD using single-cell RNA-sequencing (scRNA-seq).Methods Two scRNA-seq datasets with 106 829 high-quality cells from 34 patients including 11 normal, 9 early (stage I and II) and 14 advanced (stage III and IV) LUAD were integrated and clustered to explore diagnostic and therapeutic cell populations and their biomarkers for diverse stages of LUAD. Three independent bulk RNA-seq datasets were used to validate the results from scRNA-seq analysis. The expression of marker genes for specific cell types in early and advanced LUAD was verified by immunohistochemistry (IHC).Results Comprehensive cluster analysis identified that S100P+ epithelial and SPP1+ macrophage, positively related to poor outcomes, were preferentially enriched in advanced stage. Although the accumulation of KLRB1+CD8+ T cell and IGHA1+/IGHG1+ plasma cell both significantly associated the favourable prognosis, we also found KLRB1+CD8+ T cell decreased in advanced stage while IGHA1+/IGHG1+ plasma cells were increased. Cell-cell communication analysis showed that SPP1+ macrophage could interact with most of CD8+ subclusters through SPP1-CD44 axis. Furthermore, based on three independent bulk RNA-seq datasets, we built risk model with nine marker genes for specific cell subtypes and conducted deconvolution analysis, both supporting our results from scRNA-seq data. We finally validated the expression of four marker genes in early and advanced LUAD by IHC.Conclusion Our analyses highlight the molecular dynamics of LUAD epithelial and microenvironment and provide new targets to improve LUAD therapy.
first_indexed 2024-03-08T17:44:34Z
format Article
id doaj.art-18f9224f03494d32b35710dd002a2421
institution Directory Open Access Journal
issn 2052-4439
language English
last_indexed 2024-03-08T17:44:34Z
publishDate 2023-11-01
publisher BMJ Publishing Group
record_format Article
series BMJ Open Respiratory Research
spelling doaj.art-18f9224f03494d32b35710dd002a24212024-01-02T10:40:08ZengBMJ Publishing GroupBMJ Open Respiratory Research2052-44392023-11-0110110.1136/bmjresp-2023-001878Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinomaLei Cheng0Tianqing Chu1Haijiao Lu2Jialin Qian3Yinchen Shen4Chaoxian Zhao5Department of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaDepartment of Respiratory and Critical Care Medicine, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaShanghai Cancer Institute, Renji Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, ChinaBackground The heterogeneity of lung adenocarcinoma (LUAD) plays a vital role in determining the development of cancer and therapeutic sensitivity and significantly hinders the clinical treatment of LUAD.Objective To elucidate the cellular composition and reveal previously uncharacterised tumour microenvironment in LUAD using single-cell RNA-sequencing (scRNA-seq).Methods Two scRNA-seq datasets with 106 829 high-quality cells from 34 patients including 11 normal, 9 early (stage I and II) and 14 advanced (stage III and IV) LUAD were integrated and clustered to explore diagnostic and therapeutic cell populations and their biomarkers for diverse stages of LUAD. Three independent bulk RNA-seq datasets were used to validate the results from scRNA-seq analysis. The expression of marker genes for specific cell types in early and advanced LUAD was verified by immunohistochemistry (IHC).Results Comprehensive cluster analysis identified that S100P+ epithelial and SPP1+ macrophage, positively related to poor outcomes, were preferentially enriched in advanced stage. Although the accumulation of KLRB1+CD8+ T cell and IGHA1+/IGHG1+ plasma cell both significantly associated the favourable prognosis, we also found KLRB1+CD8+ T cell decreased in advanced stage while IGHA1+/IGHG1+ plasma cells were increased. Cell-cell communication analysis showed that SPP1+ macrophage could interact with most of CD8+ subclusters through SPP1-CD44 axis. Furthermore, based on three independent bulk RNA-seq datasets, we built risk model with nine marker genes for specific cell subtypes and conducted deconvolution analysis, both supporting our results from scRNA-seq data. We finally validated the expression of four marker genes in early and advanced LUAD by IHC.Conclusion Our analyses highlight the molecular dynamics of LUAD epithelial and microenvironment and provide new targets to improve LUAD therapy.https://bmjopenrespres.bmj.com/content/10/1/e001878.full
spellingShingle Lei Cheng
Tianqing Chu
Haijiao Lu
Jialin Qian
Yinchen Shen
Chaoxian Zhao
Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma
BMJ Open Respiratory Research
title Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma
title_full Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma
title_fullStr Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma
title_full_unstemmed Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma
title_short Single-cell RNA-sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma
title_sort single cell rna sequencing uncovers the dynamic changes of tumour immune microenvironment in advanced lung adenocarcinoma
url https://bmjopenrespres.bmj.com/content/10/1/e001878.full
work_keys_str_mv AT leicheng singlecellrnasequencinguncoversthedynamicchangesoftumourimmunemicroenvironmentinadvancedlungadenocarcinoma
AT tianqingchu singlecellrnasequencinguncoversthedynamicchangesoftumourimmunemicroenvironmentinadvancedlungadenocarcinoma
AT haijiaolu singlecellrnasequencinguncoversthedynamicchangesoftumourimmunemicroenvironmentinadvancedlungadenocarcinoma
AT jialinqian singlecellrnasequencinguncoversthedynamicchangesoftumourimmunemicroenvironmentinadvancedlungadenocarcinoma
AT yinchenshen singlecellrnasequencinguncoversthedynamicchangesoftumourimmunemicroenvironmentinadvancedlungadenocarcinoma
AT chaoxianzhao singlecellrnasequencinguncoversthedynamicchangesoftumourimmunemicroenvironmentinadvancedlungadenocarcinoma